发明授权
- 专利标题： Composition for treating HBV infection
- 专利标题（中）： 用于治疗HBV感染的组合物
-
申请号： US13388826申请日： 2010-08-06
-
公开(公告)号： US09393299B2公开(公告)日： 2016-07-19
- 发明人: Perrine Martin , Geneviève Inchauspe , Nathalie Silvestre , Doris Schmitt
- 申请人： Perrine Martin , Geneviève Inchauspe , Nathalie Silvestre , Doris Schmitt
- 申请人地址： FR Illkirch
- 专利权人： Transgene S.A.
- 当前专利权人： Transgene S.A.
- 当前专利权人地址： FR Illkirch
- 代理机构： Buchanan Ingersoll & Rooney PC
- 优先权： EP09305742 20090807
- 国际申请： PCT/EP2010/061492 WO 20100806
- 国际公布： WO2011/015656 WO 20110210
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; A61K39/29 ; A61K39/12 ; A61K39/00
摘要：
The present invention provides a composition comprising hepatitis B virus (HBV) component(s), and which may be either nucleic acid- or polypeptide-based as well as nucleic acid molecules and vectors encoding such HBV component(s). It also relates to infectious viral particles and host cells comprising such nucleic acid molecules or vectors. It also provides composition and kits of parts comprising such nucleic acid molecules, vectors, infectious viral particles or host cells and the therapeutic use thereof for preventing or treating HBV infections.
公开/授权文献
- US20130011435A1 COMPOSITION FOR TREATING HBV INFECTION 公开/授权日：2013-01-10
信息查询
